The first anniversary of Xconomy San Francisco, back in June, flew by so fast we didn’t have time to commemorate it. But today, November 14, it’s been 17 months to the day since we turned on San Francisco—the fifth city in our network of six hyperlocal sites. I thought I’d take the occasion to look back at the companies and technologies we’ve covered, and give you a bit of a preview of coming attractions.
First, the preview. If you’ve ever invited me to your office or worked with me on a story, you’ve probably heard me say “Thanks for the interview. I’m not actually sure when I’ll publish this story; I have a bit of a backlog of other articles to finish first.”
Well, the photo in the above right corner shows that backlog in graphic form. It’s my Post-It wall, showing all the local companies awaiting coverage in Xconomy. (Click on the image to see a larger version.) These are all companies where I’ve done the CEO interviews and finished the research, but haven’t had time to write the story. I created the Post-It wall about a month ago, in an effort to take to heart this lesson from David Allen, the productivity guru:
You can only do one thing at a time, so at any point in time there is going to be a huge backlog of “work.” Much of what we must do, to gain comfort and control in our knowledge-worker worlds these days, is clarifying what all that work is, objectively, in a format that provides an easy overview. We must continually renegotiate those commitments with ourselves and with others; and that’s impossible to do, unless they’re captured, clarified, and organized in some systematic way outside our psyche.
The wall is my external psyche. The blank spaces represent stories I’ve finished since I made the Post-Its. The rest are still waiting. I figure I can get through most of them by January or February, and after that I should be in a better position to say yes to new story leads. (Meanwhile, though, please don’t be offended if I have to say no to your pitch.)
Now for the look back at what my colleagues and I have accomplished in the last 17 months. What follows is a list of the companies and organizations we’ve covered in the San Francisco Bay Area since June 2010. These aren’t piddly little four-paragraph stories, mind you—for the most part, these are major, magazine-length profile of the sort Xconomy is famous for. We’ve covered many of these companies more than once, of course, but the links generally lead to the biggest story on each company.
If you glance through this list, it’ll remind you what a broad swath of stories we cover—from infotech to the life sciences to energy; from giant companies (Google, Apple, GM, Merck) to tiny ones (Convore, OhLife); from venture firms (Emergence Capital, Scale Venture Partners, Sofinnova Ventures, True Ventures) to dynamic individual entrepreneurs (Tony Coles of Onyx Pharmaceuticals, Eric Ries of “lean startup” fame). Quite a few of the companies on this list have been snapped up by other companies since our stories appeared—confirming, I think, that we were right to feature them. (Salesforce acquired Assistly, TripAdvisor acquired EveryTrail, and Dupont acquired Innovalight, just to name a few examples.) Happy browsing.
Ablexis
Abvio (Runmeter)
Achaogen
ACT Biotech
Adchemy
AdGrok
AdverseEvents.com
Affymax
Altius Education
Amazon
Amyris
AngelList
AngelPad
Animoto
Anthera Pharmaceuticals
Anybots
Anyleaf
Apple
Apture
Arch Venture Partners
Ardian
Assistly
Astia
AT Dynamics
AudioPress
AvidBiotics
Babson College
BayBio
Baydin
Beautylish
Blinkx
Box.net
BrightEdge
BroadVision
Bo.lt
Bookrenter
Bump
Calibra Medical
Canaan Partners
CarWoo
Castlight Health
Catch
Celgene
Cerus
Chegg
Chirply
Chomp
Cleave Biosciences
Climate Corporation (formerly Weatherbill)
Cocrystal Discovery
Codexis
CollabRx
Complete Genomics
Convore
Crescendo Bioscience
Crocodoc
Cyterix Pharmaceuticals
Cytokinetics
Cytomx Therapeutics
D-Rev
Digital Chocolate
DNAnexus
Doximity
E la Carte
Emergence Capital
Engine Yard
Enphase
Epocrates
Eventbrite
Evernote
Everytrail
Evri
Exelixis
Experience Project
Facebook
Facecash
Fandor
Fate Therapeutics
Five Prime Therapeutics
500 Startups
Flickr
Flipboard
Flite
Floodgate Fund
Flowtown
Fluidigm
Foodily
Fotopedia
Fridge
GazeHawk
Genentech
General Motors
Genomic Health
Get Satisfaction
GiftRocket
Gigamon
Gilead Sciences
Google
Google Ventures
GravityEight
Greenstart
HealthTap
HealthTech Capital
Hearsay Social
HelloFax
Heroku
Hewlett-Packard
Hipmunk
Hyperion Therapeutics
I-Corps
Illumina
IndieGoGo
InDinero
Inkling
Innovalight
Instructables
Intarcia Therapeutics
Intuit
Ion Torrent
iPierian
Jelli
Jennerex
Jumio
KaloBios
Keas
Khosla Ventures
Kilimanjaro Energy
Klip
KQED
Lanyrd
Latham & Watkins
LawPivot
LearnBoost
Life360
LinkedIn
Lithium Technologies
Livefyre
LiveScribe
LookSmart
LS9
Magoosh
Marketo
Marvell
Massive Health
Maveron
Meebo
Merck
Microsoft FUSE Labs
MobileWorks
Mohr Davidow Ventures
Morgenthaler Ventures
mSpot
MyPad
Nanosys
Nebula
New Venture Partners
NextBio
Nodality
Noteleaf
Novartis
nPario
oDesk
OhLife
Okta
1000memories
ON24
Onyx Pharmaceuticals
OpenAppMkt
Optimizely
Optivia Biotechnology
Pacific Biosciences
PARC
PariSoma
Path
PayNearMe
Pearl Therapeutics
PhyloTech
Pinnacle Engines
Plexxikon
Portola Pharmaceuticals
PowerReviews
PracticeFusion
Prysm
QB3
Qwiki
Rackspace
Rapportive
ReadyForZero
Recurve
Rentjuice
Ries, Eric
Rigel Pharmaceuticals
Rock Health
Rockmelt
Roku
Room 77
Ruckus Wireless
Sage Bionetworks
Salesforce.com
Sangamo Biosciences
Say Media
Scale Venture Partners
SearchReviews
Second Genome
SecondMarket
Sequenta
Shopkick
Shopwell
ShowYou
Sidereel
Siluria Technologies
Siri
Solazyme
Sofinnova Ventures
Sorbent Therapeutics
Splunk
Stanford Biodesign
Stipple
Streetline
StudentMentor
StumbleUpon
Sungevity
SunRun
Sutro Biopharma
SV Life Sciences
SwipeGood
TaskForce
TaskRabbit
Taulia
TechCrunch
TechShop
10gen
Tethys Bioscience
Third Rock Ventures
Thrutu
TIBCO
Tibion
Tilera
Tokbox
Traackr
Transphorm
TrapIt
Triangulate
TripIt
True Ventures
TRUSTe
TuneUp Media
23andMe
Twitter
UCSF
Udemy
VChatter
Vega Therapeutics
Viglink
Viewdle
Violin Memory
ViralHeat
Vivus
Vook
Walden Ventures
Walmart Labs
Waze
WePay
Whereoscope
WiseStamp
Wordnik
XDx
Xenoport
Y Combinator
Yammer
Zeachem
Zendesk
Zoho
Zurb
Author: Wade Roush
Between 2007 and 2014, I was a staff editor for Xconomy in Boston and San Francisco.
Since 2008 I've been writing a weekly opinion/review column called VOX: The Voice of Xperience. (From 2008 to 2013 the column was known as World Wide Wade.)
I've been writing about science and technology professionally since 1994. Before joining Xconomy in 2007, I was a staff member at MIT’s Technology Review from 2001 to 2006, serving as senior editor, San Francisco bureau chief, and executive editor of TechnologyReview.com. Before that, I was the Boston bureau reporter for Science, managing editor of supercomputing publications at NASA Ames Research Center, and Web editor at e-book pioneer NuvoMedia.
I have a B.A. in the history of science from Harvard College and a PhD in the history and social study of science and technology from MIT. I've published articles in Science, Technology Review, IEEE Spectrum, Encyclopaedia Brittanica, Technology and Culture, Alaska Airlines Magazine, and World Business, and I've been a guest of NPR, CNN, CNBC, NECN, WGBH and the PBS NewsHour. I'm a frequent conference participant and enjoy opportunities to moderate panel discussions and on-stage chats.
My personal site: waderoush.com
My social media coordinates:
Twitter: @wroush
Facebook: facebook.com/wade.roush
LinkedIn: linkedin.com/in/waderoush
Google+ : google.com/+WadeRoush
YouTube: youtube.com/wroush1967
Flickr: flickr.com/photos/wroush/
Pinterest: pinterest.com/waderoush/
View all posts by Wade Roush